El Futuro en el Tratamiento del Cáncer Renal - page 19

DART study: Dalantercept plus Axitinib

Marchuk DA, et al. Hum Mol Genetics 2003

Wang X, et al. Oncotarget 2016

Presented By Martin Voss at 2015 Genitourinary Cancers Symposium

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,9,10,11,12,13,14,15,16,17,18 20,21,22,23,24,25,26,27,28,29,...36